DiaMedica Therapeutics, Inc. (DMAC)
8.79
-0.54
(-5.79%)
USD |
NASDAQ |
Nov 13, 16:00
8.79
0.00 (0.00%)
After-Hours: 19:59
DiaMedica Therapeutics Shareholders Equity (Quarterly) : 38.34M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 38.34M |
| March 31, 2026 | 47.24M |
| December 31, 2025 | 56.11M |
| September 30, 2025 | 51.62M |
| June 30, 2025 | 27.17M |
| March 31, 2025 | 33.95M |
| December 31, 2024 | 40.72M |
| September 30, 2024 | 47.96M |
| June 30, 2024 | 53.42M |
| March 31, 2024 | 46.35M |
| December 31, 2023 | 51.06M |
| September 30, 2023 | 55.63M |
| June 30, 2023 | 59.74M |
| March 31, 2023 | 27.02M |
| December 31, 2022 | 31.83M |
| September 30, 2022 | 35.08M |
| June 30, 2022 | 37.72M |
| March 31, 2022 | 40.77M |
| December 31, 2021 | 44.02M |
| September 30, 2021 | 47.04M |
| June 30, 2021 | 20.32M |
| March 31, 2021 | 23.14M |
| December 31, 2020 | 26.01M |
| September 30, 2020 | 29.76M |
| June 30, 2020 | 11.27M |
| Date | Value |
|---|---|
| March 31, 2020 | 13.32M |
| December 31, 2019 | 7.617M |
| September 30, 2019 | 9.70M |
| June 30, 2019 | 11.70M |
| March 31, 2019 | 13.91M |
| December 31, 2018 | |
| September 30, 2018 | 1.343M |
| June 30, 2018 | 1.465M |
| March 31, 2018 | 4.733M |
| December 31, 2017 | 0.792M |
| September 30, 2017 | -0.0309M |
| June 30, 2017 | 0.7319M |
| March 31, 2017 | 0.0053M |
| December 31, 2016 | |
| September 30, 2016 | 1.619M |
| June 30, 2016 | -1.036M |
| March 31, 2016 | -1.017M |
| December 31, 2015 | -1.228M |
| September 30, 2015 | -1.147M |
| June 30, 2015 | -0.9348M |
| March 31, 2015 | -1.379M |
| December 31, 2014 | -1.532M |
| September 30, 2014 | -0.7099M |
| June 30, 2014 | 0.0862M |
| March 31, 2014 | -0.3985M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Nektar Therapeutics | 903.12M |
| Fortress Biotech, Inc. | 164.14M |
| ACADIA Pharmaceuticals, Inc. | 1.387B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 45.00M |
| Total Liabilities (Quarterly) | 6.663M |
| Debt to Equity Ratio | 0.0048 |
| Current Ratio | 6.720 |
| Net Debt Paydown Yield | 0.01% |